PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-14

Date Title Company
14-Nov-2024 Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer Coronado Research
14-Nov-2024 Cellev8 Nutrition Inc (Formerly Preferred Commerce) Clarifies Business Focus and Highlights Benefits of Superoxide Dismutase Supplements AccessWire
14-Nov-2024 Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study AccessWire
14-Nov-2024 MDaudit’s 2024 Benchmark Report Reveals a Fivefold Increase in Dollars At-Risk from Payer Audits while Coding-Related Denials Surged by Over 125% AccessWire
14-Nov-2024 Swell Launches Employee Experience Insights to Give Healthcare Organizations Real-Time Employee Feedback AccessWire
14-Nov-2024 Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors Marinomed Biotech AG
14-Nov-2024 IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline AccessWire
14-Nov-2024 Zane Networks Awarded Blanket Purchase Agreement for Health and Human Services' Health IT Alignment Initiative AccessWire
14-Nov-2024 Enalare Therapeutics is Granted a New Patent for ENA-001, Extending Its Exclusivity in the U.S. to 2043 Newswire
14-Nov-2024 Nitches Inc. Announces InTheZone Labs' Launch on ShareASale, One of the World’s Leading Affiliate Networks Newswire
14-Nov-2024 Enalare Therapeutics is Granted a New Patent for ENA-001, Extending Its Exclusivity in the U.S. to 2043 AccessWire
14-Nov-2024 In full bloom: WEECO Pharma boosts SYNBIOTIC's sales SYNBIOTIC SE
14-Nov-2024 Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments AccessWire
14-Nov-2024 Interactive Strength Inc. (Nasdaq:TRNR) Reports Third Quarter 2024 Results AccessWire
14-Nov-2024 2BScientific Limited announces opening of a new European hub in Germany 2BScientific
14-Nov-2024 SynbiCITE awarded £3m EPSRC grant to expand engineering biology proof-of-concept programme SynbiCITE
14-Nov-2024 Neuraxpharm reports another year of sustained growth and international expansion Neuraxpharm Group
14-Nov-2024 Vivet Therapeutics to Present Key Findings on its Gene Therapy Program for Cerebrotendinous Xanthomatosis at the American Association for the Study of Liver Diseases Annual Meeting Vivet Therapeutics
14-Nov-2024 Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial Xeltis
14-Nov-2024 Vivet Therapeutics to Present Key Findings on its Gene Therapy Program for Cerebrotendinous Xanthomatosis at the American Association for the Study of Liver Diseases Annual Meeting Vivet Therapeutics